Check pharmacology, toxicology and pharmaceutics papers: citations, claims and retractions

A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines

Farrington, P., Rush, M., Miller, E., Pugh, S., Colville, A., Flower, A., Nash, J., & Morgan-Capner, P. (1995) · The Lancet

Pharmacovigilance and Adverse Drug ReactionsBacterial Infections and Vaccines

Cited by 338

Guidelines international network: Principles for disclosure of interests and management of conflicts in guidelines

Schünemann, H. J., Al-Ansary, L. A., Forland, F., Kersten, S., Komulainen, J., Kopp, I. B., Macbeth, F., Phillips, S. M., Robbins, C., van der Wees, P., et al. (2015) · Annals of Internal Medicine

Pharmaceutical industry and healthcareClinical practice guidelines implementation

Cited by 337

Performance assessment and economic analysis of a human Liver-Chip for predictive toxicology

Ewart, L., Apostolou, A., Briggs, S. A., Carman, C. V., Chaff, J. T., Heng, A. R., Jadalannagari, S., Janardhanan, J., Jang, K.-J., Joshipura, S. R., et al. (2022) · Communications Medicine

Drug-Induced Hepatotoxicity and Protection3D Printing in Biomedical Research

Cited by 337

Compliance with legal requirement to report clinical trial results on ClinicalTrials.gov: a cohort study

DeVito, N. J., Bacon, S., & Goldacre, B. (2020) · The Lancet

Pharmaceutical industry and healthcareAcademic Publishing and Open Access

Cited by 336

Case-non-case studies: principle, methods, bias and interpretation

Faillie, J.-L. (2019) · Therapies

Pharmacovigilance and Adverse Drug ReactionsStatistical Methods in Clinical Trials

Cited by 336

Flavin containing monooxygenase 3 exerts broad effects on glucose and lipid metabolism and atherosclerosis

Shih, D. M., Wang, Z., Lee, R., Meng, Y., Che, N., Charugundla, S., Qi, H., Wu, J., Pan, C., Brown, J. M., et al. (2015) · Journal of Lipid Research

Pharmacogenetics and Drug MetabolismLipid metabolism and disorders

Cited by 335

Methods to Compare Dissolution Profiles and a Rationale for Wide Dissolution Specifications for Metoprolol Tartrate tablets†

Polli, J. E., Rekhi, G. S., Augsburger, L. L., & Shah, V. P. (1997) · Journal of Pharmaceutical Sciences

Drug Solubulity and Delivery SystemsAnalytical Methods in Pharmaceuticals

Cited by 334

Relative Enzymatic Activity, Protein Stability, and Tissue Distribution of Human Steroid-Metabolizing UGT2B Subfamily Members**This work was supported by the Medical Research Council of Canada, the Fonds de la Recherche en Sante du Quebec, and Endorecherche.

Turgeon, D., Carrier, J.-S., Lévesque, E., Hum, D. W., & Bélanger, A. (2001) · Endocrinology

Pharmacogenetics and Drug MetabolismDrug Transport and Resistance Mechanisms

Cited by 333

The increase in urinary excretion of 6 beta-hydroxycortisol as a marker of human hepatic cytochrome P450IIIA induction

Ged, C., Rouillon, J., Pichard, L., Combalbert, J., Bressot, N., Bories, P., Michel, H., Beaune, P., & Maurel, P. (1989) · British Journal of Clinical Pharmacology

Pharmacogenetics and Drug MetabolismAdrenal Hormones and Disorders

Cited by 333

Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic: A China perspective

Zheng, S.-Q., Yang, L., Zhou, P.-X., Li, H.-B., Liu, F., & Zhao, R.-S. (2021) · Research in Social and Administrative Pharmacy

Pharmacy and Medical PracticesPharmaceutical Practices and Patient Outcomes

Cited by 333

Clinical Pharmacokinetics of Amiodarone

Latini, R., Tognoni, G., & Kates, R. E. (1984) · Clinical Pharmacokinetics

Pharmacogenetics and Drug MetabolismCardiac electrophysiology and arrhythmias

Cited by 333

The Chemical Biology of Naphthoquinones and Its Environmental Implications

Kumagai, Y., Shinkai, Y., Miura, T., & Cho, A. K. (2012) · Annual Review of Pharmacology and Toxicology

Bioactive Compounds and Antitumor AgentsGenomics, phytochemicals, and oxidative stress

Cited by 332

Effects of petrolatum on stratum corneum structure and function

Ghadially, R., Halkier-Sorensen, L., & Elias, P. M. (1992) · Journal of the American Academy of Dermatology

Advancements in Transdermal Drug DeliveryDermatology and Skin Diseases

Cited by 332

Trial Reporting in ClinicalTrials.gov — The Final Rule

Zarin, D. A., Tse, T., Williams, R. J., & Carr, S. (2016) · New England Journal of Medicine

Pharmaceutical industry and healthcareEthics in Clinical Research

Cited by 332

Outcome Reporting Among Drug Trials Registered in ClinicalTrials.gov

Bourgeois, F. T., Murthy, S., & Mandl, K. D. (2010) · Annals of Internal Medicine

Pharmaceutical industry and healthcareStatistical Methods in Clinical Trials

Cited by 332

Chemokines and mitochondrial products activate neutrophils to amplify organ injury during mouse acute liver failure

Marques, P. E., Amaral, S. S., Pires, D. A., Nogueira, L. L., Soriani, F. M., Lima, B. H. F., Lopes, G. A. O., Russo, R. C., Ávila, T. V., Melgaço, J. G., et al. (2012) · Hepatology

Drug-Induced Hepatotoxicity and ProtectionNeutrophil, Myeloperoxidase and Oxidative Mechanisms

Cited by 332

Genomic organization of the human catechol O‐methyltransferase gene and its expression from two distinct promoters

TENHUNEN, J., SALMINEN, M., LUNDSTRÖM, K., KIVILUOTO, T., SAVOLAINEN, R., & ULMANEN, I. (1994) · European Journal of Biochemistry

Pharmacogenetics and Drug MetabolismGenomics and Chromatin Dynamics

Cited by 331

PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination

Garinot, M., Fiévez, V., Pourcelle, V., Stoffelbach, F., des Rieux, A., Plapied, L., Theate, I., Freichels, H., Jérôme, C., Marchand-Brynaert, J., et al. (2007) · Journal of Controlled Release

Advanced Drug Delivery SystemsNanoparticle-Based Drug Delivery

Cited by 331

Suprachoroidal drug delivery to the back of the eye using hollow microneedles

Patel, S. R., Lin, A. S. P., Edelhauser, H. F., & Prausnitz, M. R. (2011) · Pharmaceutical Research

Advanced Drug Delivery SystemsAdvancements in Transdermal Drug Delivery

Cited by 330

Genetic susceptibility to adverse drug reactions

Pirmohamed, M., & Park, B. K. (2001) · Trends in Pharmacological Sciences

Pharmacogenetics and Drug MetabolismDrug-Induced Adverse Reactions

Cited by 328

Reporting Bias in Drug Trials Submitted to the Food and Drug Administration: Review of Publication and Presentation

Rising, K., Bacchetti, P., & Bero, L. (2008) · PLoS Medicine

Pharmaceutical industry and healthcareMeta-analysis and systematic reviews

Cited by 328

Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury

Proctor, W. R., Foster, A. J., Vogt, J., Summers, C., Middleton, B., Pilling, M. A., Shienson, D., Kijanska, M., Ströbel, S., Kelm, J. M., et al. (2017) · Archives of Toxicology

Drug-Induced Hepatotoxicity and ProtectionAnimal testing and alternatives

Cited by 328

Comparison of Hepatic 2D Sandwich Cultures and 3D Spheroids for Long-term Toxicity Applications: A Multicenter Study

Bell, C. C., Dankers, A. C. A., Lauschke, V. M., Sison-Young, R., Jenkins, R., Rowe, C., Goldring, C. E., Park, K., Regan, S. L., Walker, T., et al. (2018) · Toxicological Sciences

Drug-Induced Hepatotoxicity and ProtectionAnimal testing and alternatives

Cited by 327

Chemokine (C‐C motif) receptor 2–positive monocytes aggravate the early phase of acetaminophen‐induced acute liver injury

Mossanen, J. C., Krenkel, O., Ergen, C., Govaere, O., Liepelt, A., Puengel, T., Heymann, F., Kalthoff, S., Lefebvre, E., Eulberg, D., et al. (2016) · Hepatology

Drug-Induced Hepatotoxicity and ProtectionLiver physiology and pathology

Cited by 325